Allosteric Modulators of the Class A G Protein Coupled Receptors
- PMID: 27236557
- DOI: 10.1007/978-3-319-32805-8_9
Allosteric Modulators of the Class A G Protein Coupled Receptors
Abstract
Allosteric modulation is the regulation of a protein by binding of an effector molecule at the proteins allosteric site (a site other than that of the endogenous ligand). Allosteric modulators, by virtue of the fact that they may stabilize different global conformations of a receptor, have the potential to disrupt protein-protein interactions of very large proteins and elicit diverse functional responses. The existence of ligands that allosterically modulate the G protein receptor (GPCR) functions provides both challenges and opportunities for drug development campaigns. A number of therapeutic advantages of allosteric modulators over classic orthosteric ligands were proposed, involving nature of response, improved selectivity and ligand-directed signaling. In this review I discuss various aspects of allosteric modulation of GPCRs, which arise from the interactions of receptors with synthetic or endogenous small molecules, ions, lipids and diverse proteins. Detection and quantification of allosteric modulation will be also addressed. In the conclusion I will present future opportunities and challenges in the development of allosteric modulators as therapeutics.
Keywords: Allosteric modulation; Allosteric modulators; G protein coupled receptor s; Protein-protein interaction; Therapeutics.
Similar articles
-
Strategies for the identification of allosteric modulators of G-protein-coupled receptors.Biochem Pharmacol. 2011 Mar 15;81(6):691-702. doi: 10.1016/j.bcp.2010.12.012. Epub 2010 Dec 22. Biochem Pharmacol. 2011. PMID: 21184747 Review.
-
Allosteric modulation of G-protein coupled receptors.Eur J Pharm Sci. 2004 Mar;21(4):407-20. doi: 10.1016/j.ejps.2003.11.007. Eur J Pharm Sci. 2004. PMID: 14998571 Review.
-
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.J Med Chem. 2019 Jan 10;62(1):24-45. doi: 10.1021/acs.jmedchem.7b01844. Epub 2018 Feb 26. J Med Chem. 2019. PMID: 29457894
-
Allosteric modulation of G protein-coupled receptors.Annu Rev Pharmacol Toxicol. 2007;47:1-51. doi: 10.1146/annurev.pharmtox.47.120505.105159. Annu Rev Pharmacol Toxicol. 2007. PMID: 17009927 Review.
-
Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:89-107. doi: 10.1146/annurev-pharmtox-010919-023301. Epub 2019 Aug 27. Annu Rev Pharmacol Toxicol. 2020. PMID: 31454292 Free PMC article. Review.
Cited by
-
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage.Sci Rep. 2017 Aug 25;7(1):9560. doi: 10.1038/s41598-017-09808-8. Sci Rep. 2017. PMID: 28842619 Free PMC article.
-
Analyzing In Silico the Relationship Between the Activation of the Edema Factor and Its Interaction With Calmodulin.Front Mol Biosci. 2020 Dec 4;7:586544. doi: 10.3389/fmolb.2020.586544. eCollection 2020. Front Mol Biosci. 2020. PMID: 33344505 Free PMC article.
-
The cannabinoid CB2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro.J Recept Signal Transduct Res. 2024 Aug;44(4):151-159. doi: 10.1080/10799893.2024.2431986. Epub 2024 Nov 22. J Recept Signal Transduct Res. 2024. PMID: 39575892
-
The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT).J Endocrinol Invest. 2018 Jan;41(1):67-73. doi: 10.1007/s40618-017-0716-9. Epub 2017 Jun 21. J Endocrinol Invest. 2018. PMID: 28639207 Review.
-
Mechanistic insights into allosteric regulation of the A2A adenosine G protein-coupled receptor by physiological cations.Nat Commun. 2018 Apr 10;9(1):1372. doi: 10.1038/s41467-018-03314-9. Nat Commun. 2018. PMID: 29636462 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources